Apr 29, 2020

By Bob Komsic

Share on
The makers of remdesivir and Washington say a major study’s shown the drug shortens the recovery time from COVID-19 by four days on average.
It’s the first treatment to pass such a strict test.
The study, conducted by the National Institutes of Health, tested it versus usual care in over 1,000 hospitalized coronavirus patients around the world.
N-I-H’s Dr. Anthony Fauci says remdesivir was able to reduce the recovery of patients by 31% — 11 days on average versus 15 days for those given usual care.
Dr. Fauci says what it’s proven is that a drug can block the virus.
”This will be the standard of care.”
He adds there was also a trend toward fewer deaths among those taking remdesivir, and that results would soon be published in a medical journal.
The U.S. Food and Drug Administration has been talking with the makers of the drug ”regarding making remdesivir available to patients as quickly as possible, as appropriate.”
Having a treatment could have a major impact on the pandemic since health experts say any vaccine is likely a year, or more, away.
Advertise With Us

To learn about advertising opportunities with Zoomer Radio use the link below:

Join Our Fan Club
Coverage Area
Downtown Toronto
Toronto HD
96.3 HD-2
Kingston to Windsor, Parry Sound to Pittsburgh
ZoomerRadio Logo

Recently Played: